BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22782852)

  • 1. Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia.
    Liu W; Wu L; Shen XM; Shi LJ; Zhang CP; Xu LQ; Zhou ZT
    Int J Cancer; 2013 Feb; 132(4):868-74. PubMed ID: 22782852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes.
    Roudi R; Korourian A; Shariftabrizi A; Madjd Z
    Cancer Invest; 2015; 33(7):294-302. PubMed ID: 26046383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
    Sun L; Feng J; Ma L; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cancer stem cell markers ALDH1 and Bmi1 in oral erythroplakia and the risk of oral cancer.
    Feng JQ; Xu ZY; Shi LJ; Wu L; Liu W; Zhou ZT
    J Oral Pathol Med; 2013 Feb; 42(2):148-53. PubMed ID: 22725270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
    Wakamatsu Y; Sakamoto N; Oo HZ; Naito Y; Uraoka N; Anami K; Sentani K; Oue N; Yasui W
    Pathol Int; 2012 Feb; 62(2):112-9. PubMed ID: 22243781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological Significance of CD133 and ALDH1 Cancer Stem Cell Marker Expression in Invasive Ductal Breast Carcinoma.
    Mansour SF; Atwa MM
    Asian Pac J Cancer Prev; 2015; 16(17):7491-6. PubMed ID: 26625750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
    Kapucuoğlu N; Bozkurt KK; Başpınar Ş; Koçer M; Eroğlu HE; Akdeniz R; Akçil M
    Pathol Res Pract; 2015 Oct; 211(10):740-7. PubMed ID: 26298632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.
    Shien K; Toyooka S; Ichimura K; Soh J; Furukawa M; Maki Y; Muraoka T; Tanaka N; Ueno T; Asano H; Tsukuda K; Yamane M; Oto T; Kiura K; Miyoshi S
    Lung Cancer; 2012 Jul; 77(1):162-7. PubMed ID: 22387005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
    Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
    Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
    Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer.
    Ayub TH; Keyver-Paik MD; Debald M; Rostamzadeh B; Thiesler T; Schröder L; Barchet W; Abramian A; Kaiser C; Kristiansen G; Kuhn W; Kübler K
    Oncotarget; 2015 Jun; 6(18):16437-48. PubMed ID: 25999351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus.
    Xu Z; Shen Z; Shi L; Sun H; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Oct; 17(5):408-11. PubMed ID: 23707659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adherent culture of CD133+ cells in glioblastomas and expression of ADLH1].
    Wang P; Mao Q; Wang X; Chen MN; Gan LA; Liu YH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):413-6. PubMed ID: 21827011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy.
    Mizukami T; Kamachi H; Mitsuhashi T; Tsuruga Y; Hatanaka Y; Kamiyama T; Matsuno Y; Taketomi A
    BMC Cancer; 2014 Sep; 14():687. PubMed ID: 25240521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro.
    Mihatsch J; Toulany M; Bareiss PM; Grimm S; Lengerke C; Kehlbach R; Rodemann HP
    Radiother Oncol; 2011 Jun; 99(3):300-6. PubMed ID: 21704411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.
    Currie MJ; Beardsley BE; Harris GC; Gunningham SP; Dachs GU; Dijkstra B; Morrin HR; Wells JE; Robinson BA
    Hum Pathol; 2013 Mar; 44(3):402-11. PubMed ID: 23036368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CD133(+) Colo205 colorectal cancer cells express high levels of ALDH1 in serum-free culture].
    Li L; Zhang S; Liang F; Lin Y; Li R; Chen C; Xiao B
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):889-93. PubMed ID: 23803205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALDH1 is a prognostic factor for patients treated with neoadjuvant chemoradiotherapy and radical resection for stage III rectal cancer.
    Oh SY; Sohn SH; Yim H; Lee D; Suh KW; Kim YB
    J Surg Oncol; 2015 Feb; 111(2):243-7. PubMed ID: 25270363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study.
    Liu W; Feng JQ; Shen XM; Wang HY; Liu Y; Zhou ZT
    Cancer; 2012 Mar; 118(6):1693-700. PubMed ID: 22009787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma--their prognostic significance.
    Okudela K; Woo T; Mitsui H; Tajiri M; Masuda M; Ohashi K
    Pathol Int; 2012 Dec; 62(12):792-801. PubMed ID: 23252868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.